At Series B, the founder-led sales motion that got you to this point will not carry you to $50M ARR.
I know this because I have watched it fail at close range. Across more than 75 startups I have advised and the six portfolio companies where I have directly rebuilt the GTM engine, the pattern is consistent. The motion that generated the first $5M in revenue becomes the constraint that prevents the next $20M.
"This is not a failure of execution. It is a structural mismatch between the motion that works at one stage and the motion required at the next."
Recognising that mismatch early is worth millions in avoided waste and months of recovered time.
The Three Fractures That Break Series B GTM
Fracture 1: The Founder Is Still the Sales Process
In the earliest stages, founder-led sales is an advantage. Nobody can articulate the vision, handle technical objections, and close on conviction the way the person who built the product can.
The problem is not that founder-led sales worked. The problem is that nobody built the translation layer between what the founder does instinctively and what a team can do systematically.
I see this in at least half of the Series B companies I work with. The founder closes a $400K deal through a combination of personal relationships, improvisational product demos, and late-night emails with the prospect's CTO. Then they hire three reps and expect them to replicate the result. The reps cannot, because the "process" was never a process. It was the founder being themselves.
The Fix
Before you hire your next rep, sit with your founder for two hours and document every step of the last five closed-won deals. Not the CRM stages. The actual sequence of conversations, the objections that surfaced, the moments where the deal almost died and what saved it, the internal champion who moved things forward, and the evidence that finally tipped the decision.
That extraction becomes the foundation of your first real sales playbook. It will not be perfect. It will be incomplete. But it will be real, and it will give your new hires something to work from that is grounded in how your buyers actually buy.
Fracture 2: The ICP Has Drifted
Early-stage companies sell to whoever will buy. This is rational behaviour when you need revenue to survive and data to learn from. But by Series B, the pattern of who buys well — closes faster, retains longer, expands more — should be visible in your data.
Most Series B companies have not done this analysis. They have a vague ICP statement on a slide somewhere but no rigorous segmentation based on actual deal outcomes.
The consequence is scattered pipeline. Reps chase every lead with equal intensity because the company has not told them which accounts deserve disproportionate effort. Win rates stay low. Sales cycles stay long. The board sees pipeline coverage at 4x and wonders why revenue is not materialising.
The Fix
Pull your last 20 closed-won deals and your last 20 closed-lost deals. For each one, document: industry vertical, company size, buyer title, use case, competitive displacement, sales cycle length, and contract value. The patterns will be obvious and uncomfortable. You will discover that 80% of your revenue comes from a segment that represents 30% of your pipeline.
Narrowing the ICP feels counterintuitive when you are under pressure to grow. But focused targeting consistently produces faster revenue growth than broad targeting.
Fracture 3: The Narrative Does Not Scale
The founder's pitch works because the founder delivers it. Their conviction, their track record, their ability to read the room and adjust in real time. That is not a narrative. That is a performance.
A scalable GTM narrative needs to work in a cold email, in a first-call deck, in a proposal, and on a website. It needs to resonate whether the person delivering it has ten years of industry experience or ten months.
I rebuilt the narrative for a healthcare AI company that had been describing themselves as "an AI-powered clinical documentation platform." Accurate, but forgettable.
"Health systems lose an average of $1.2M per year per facility to incomplete clinical documentation. We recover 60% of that within the first six months."
Same product. Completely different conversation. The first version invites a feature comparison. The second version invites a financial discussion. In enterprise sales, you always want to be in the financial discussion.
The 90-Day GTM Transition Blueprint
Days 1–14: Extraction and Audit
Conduct founder knowledge extraction sessions. Document the real sales process — not the CRM version. Run the deal-level ICP audit. Identify your best-fit segment and your highest-risk pipeline.
Days 15–30: Narrative Rebuild
Rewrite the core narrative around the buyer's problem, not your product's features. Pressure-test it against three to five prospects who already know you. Revise based on what makes them lean forward versus what makes them nod politely.
Days 31–60: Playbook and Enablement
Build the sales playbook from the extraction sessions. Include discovery call frameworks, objection handling guides, competitive positioning, and qualification criteria. Train the team on the playbook using real pipeline, not hypothetical scenarios.
Days 61–90: Measurement and Iteration
Deploy the new motion. Measure win rate by segment, average sales cycle length, pipeline generation by source, and conversion at each stage. Hold weekly pipeline reviews that focus on deal quality, not deal volume. Iterate the playbook based on what the data reveals, not what the loudest rep insists.
The Three Metrics That Tell You It Is Working
Win rate by ICP segment. If your win rate in your best-fit segment is not measurably higher than your blended average, either your segmentation is wrong or your narrative is not landing with the right buyers.
Average sales cycle in days. A well-targeted, well-narrated GTM motion should shorten cycles by 20 to 30% within the first quarter. If cycles are not compressing, the likely culprit is poor qualification.
Pipeline generation cost per qualified opportunity. Track this by channel and by segment. If your cost-per-qualified-opportunity is climbing despite increased activity, you are scaling the wrong motion.
Frequently Asked Questions
What is the most common go-to-market mistake at Series B?
Scaling headcount before the sales process is documented and repeatable. Adding reps amplifies whatever motion exists. If the motion is undocumented and founder-dependent, you are paying six-figure salaries for people to guess at what works. Document first. Hire second.
How do you transition from founder-led sales to a scalable GTM motion?
Start with extraction: systematically document how the founder actually sells, including the informal steps that never appear in a CRM. Then build a playbook that translates those instincts into a process others can follow. The founder's role shifts from closing every deal to coaching reps on how to close and intervening only in strategic moments.
What is a GTM sprint?
A focused, time-bound engagement — typically two to four weeks — that audits and rebuilds the core elements of a company's go-to-market strategy: ICP definition, narrative and positioning, sales process, pipeline architecture, and measurement framework. It produces a deployable playbook, not a strategy deck.
How do you know when your Series B GTM motion needs a reset?
Three signals: (1) Win rates are flat or declining despite growing pipeline. (2) Sales cycles are lengthening as you move upmarket. (3) New reps take longer than 90 days to generate their first qualified opportunity. Any one of these suggests structural issues in the motion, not individual performance gaps.
Work with Brett
I run this exact playbook in a four-week GTM Sprint for Series A and above enterprise companies. If any of these fractures sound familiar, book a discovery call and we will diagnose which one is costing you the most.